Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Large-scale testing (Phase 3)Enrolling By InvitationNCT05678933
What this trial is testing

AC-CHOP Versus CHOP in Patients With Previously Untreated PTCL-TFH

Who this might be right for
Peripheral T-cell Lymphoma Targeted Therapy
Tianjin Medical University Cancer Institute and Hospital 200
Large-scale testing (Phase 3)Looking for participantsNCT06522737
What this trial is testing

Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype

Who this might be right for
Lymphoma
SecuraBio 124
Large-scale testing (Phase 3)Looking for participantsNCT06561048
What this trial is testing

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

Who this might be right for
Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedAngioimmunoblastic T-cell LymphomaFollicular T-Cell Lymphoma+4 more
Corvus Pharmaceuticals, Inc. 150
Testing effectiveness (Phase 2)Study completedNCT02464228
What this trial is testing

Investigation of Tipifarnib in Treatment of Subjects With Peripheral T-Cell Lymphoma (PTCL) That Have Not Responded to Standard Therapy

Who this might be right for
Relapsed or Refractory Peripheral T-Cell Lymphoma
Kura Oncology, Inc. 65
Testing effectiveness (Phase 2)Looking for participantsNCT06035497
What this trial is testing

Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)

Who this might be right for
Relapsed or Refractory T-cell Lymphomas
Bristol-Myers Squibb 85
Large-scale testing (Phase 3)Looking for participantsNCT06947967
What this trial is testing

Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype

Who this might be right for
Lymphoma, T-Cell, Peripheral
Chipscreen Biosciences, Ltd. 224
Testing effectiveness (Phase 2)Looking for participantsNCT05230680
What this trial is testing

Azacitidine-CHOP for Patients With Nodal T-cell Lymphoma With T-follicular Helper Phenotype (ACANTUS)

Who this might be right for
T Cell Lymphoma
Won Seog Kim 41
Testing effectiveness (Phase 2)Looking for participantsNCT05572983
What this trial is testing

Phase Ⅱ Study of Chidamide in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype

Who this might be right for
Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype
Sun Yat-sen University 47